400 related articles for article (PubMed ID: 3137264)
1. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.
Cogné M; Bakhshi A; Korsmeyer SJ; Guglielmi P
J Immunol; 1988 Sep; 141(5):1738-44. PubMed ID: 3137264
[TBL] [Abstract][Full Text] [Related]
2. Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein.
Guglielmi P; Bakhshi A; Cogne M; Seligmann M; Korsmeyer SJ
J Immunol; 1988 Sep; 141(5):1762-8. PubMed ID: 3137265
[TBL] [Abstract][Full Text] [Related]
3. Gamma heavy chain disease in man: independent structural abnormalities and reduced transcription of a functionally rearranged lambda L-chain gene result in the absence of L-chains.
Teng MH; Rosen S; Gorny MK; Alexander A; Buxbaum J
Blood Cells Mol Dis; 2000 Jun; 26(3):177-85. PubMed ID: 10950937
[TBL] [Abstract][Full Text] [Related]
4. The productive gene for alpha-H chain disease protein MAL is highly modified by insertion-deletion processes.
Tsapis A; Bentaboulet M; Pellet P; Mihaesco E; Thierry D; Seligmann M; Brouet JC
J Immunol; 1989 Dec; 143(11):3821-7. PubMed ID: 2555418
[TBL] [Abstract][Full Text] [Related]
5. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region.
Bentaboulet M; Mihaesco E; Gendron MC; Brouet JC; Tsapis A
Eur J Immunol; 1989 Nov; 19(11):2093-8. PubMed ID: 2513209
[TBL] [Abstract][Full Text] [Related]
6. Exon skipping without splice site mutation accounting for abnormal immunoglobulin chains in nonsecretory human myeloma.
Cogné M; Guglielmi P
Eur J Immunol; 1993 Jun; 23(6):1289-93. PubMed ID: 8500524
[TBL] [Abstract][Full Text] [Related]
7. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
[TBL] [Abstract][Full Text] [Related]
8. Articular, monoclonal gamma3 heavy-chain deposition disease: characterization of a partially deleted heavy-chain gene and its protein product synthesized in vivo and in vitro.
Thompson KM; Sletten K; Brandtzaeg P; Källberg E; Wien TN; Husby G
Arthritis Rheum; 2003 Nov; 48(11):3266-71. PubMed ID: 14613292
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin light chain transcripts with altered V regions in Burkitt's lymphoma cell lines producing short mu chains.
Cogné M; Mounir S; Aucouturier P; Preud'homme JL; Nau F; Guglielmi P
Eur J Immunol; 1990 Sep; 20(9):1905-10. PubMed ID: 2120068
[TBL] [Abstract][Full Text] [Related]
10. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
[TBL] [Abstract][Full Text] [Related]
11. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
Schlissel MS; Morrow T
J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
[TBL] [Abstract][Full Text] [Related]
12. Use of the most JH-proximal human Ig H chain V region gene, VH6, in the expressed immune repertoire.
Varade WS; Marin E; Kittelberger AM; Insel RA
J Immunol; 1993 Jun; 150(11):4985-95. PubMed ID: 8496600
[TBL] [Abstract][Full Text] [Related]
13. V gene rearrangement is required to fully activate the hypermutation mechanism in B cells.
Roes J; Hüppi K; Rajewsky K; Sablitzky F
J Immunol; 1989 Feb; 142(3):1022-6. PubMed ID: 2492327
[TBL] [Abstract][Full Text] [Related]
14. Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus.
Weber JS; Berry J; Manser T; Claflin JL
J Immunol; 1991 May; 146(10):3652-5. PubMed ID: 1902859
[TBL] [Abstract][Full Text] [Related]
15. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
16. Characterization of allelic V kappa-1 region genes in inbred strains of mice.
Ng KH; Lavigueur A; Ricard L; Boivrette M; Maclean S; Cloutier D; Gibson DM
J Immunol; 1989 Jul; 143(2):638-48. PubMed ID: 2567773
[TBL] [Abstract][Full Text] [Related]
17. Mutations in Ig V(D)J genes are distributed asymmetrically and independently of the position of V(D)J.
Weber JS; Berry J; Manser T; Claflin JL
J Immunol; 1994 Oct; 153(8):3594-602. PubMed ID: 7930582
[TBL] [Abstract][Full Text] [Related]
18. Variable kappa gene rearrangement in lymphoproliferative disorders: an analysis of V kappa gene usage, VJ joining and somatic mutation.
Cannell PK; Amlot P; Attard M; Hoffbrand AV; Foroni L
Leukemia; 1994 Jul; 8(7):1139-45. PubMed ID: 8035605
[TBL] [Abstract][Full Text] [Related]
19. Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection.
Pennell CA; Mercolino TJ; Grdina TA; Arnold LW; Haughton G; Clarke SH
Eur J Immunol; 1989 Jul; 19(7):1289-95. PubMed ID: 2503389
[TBL] [Abstract][Full Text] [Related]
20. Expressed human immunoglobulin kappa genes and their hypermutation.
Klein R; Jaenichen R; Zachau HG
Eur J Immunol; 1993 Dec; 23(12):3248-62. PubMed ID: 8258341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
